Basic Body Awareness Therapy for Healthy Young Adults
An Investigation Into the Effects of Basic Body Awareness Therapy on Musculoskeletal Pain, Spinal Mobility, Balance and Flexibility
Background:
Musculoskeletal pain, impaired postural control, and reduced movement quality are increasingly observed among young adults, partly due to sedentary lifestyles and insufficient physical activity. Basic Body Awareness Therapy (BBAT) is a physiotherapy-based mind-body approach designed to enhance body awareness, movement quality, balance, and postural stability through controlled functional movements. Although BBAT has demonstrated beneficial effects in various clinical populations, evidence regarding its effectiveness in healthy young adults remains limited.
Objective:This study aims to investigate the effects of a 12-week BBAT program on balance, musculoskeletal pain, spinal mobility, and flexibility in healthy young adults.
Methods:This randomized controlled trial will be conducted at the Healthy Living Laboratory of the University of Health Sciences, Gülhane Faculty of Physiotherapy and Rehabilitation, between June 2026 and May 2027. Healthy individuals aged 18-40 years will be recruited through voluntary participation and social media announcements. Participants will be randomly assigned to either a BBAT intervention group or a control group. The intervention group will participate in supervised BBAT sessions once weekly for 12 weeks, with each session lasting 45-60 minutes, while the control group will receive no intervention. Eligible participants will be individuals aged 18-40 years who have not participated in structured body-awareness-based exercise programs, such as BBAT, yoga, or Pilates, within the previous six months and who are able to complete all assessment procedures independently. Individuals with neurological, vestibular, rheumatological, or severe orthopedic disorders, recent surgery or injury affecting the spine or lower extremities, pregnancy, acute infection, or medication use affecting balance will be excluded.
Spinal mobility and flexibility will be the primary outcome measure. Secondary outcomes will include musculoskeletal pain and balance. Assessments will be performed before and after the intervention period.
A tanulmány áttekintése
Részletes leírás
Background:
Musculoskeletal pain, postural control impairments, and reduced movement quality are increasingly prevalent among young adults, partly due to sedentary lifestyles and low physical activity levels. Basic Body Awareness Therapy (BBAT) is a physiotherapy-based mind-body approach that aims to improve body awareness, postural stability, movement quality, and balance through controlled functional movements. Although BBAT has demonstrated beneficial effects in various clinical populations, evidence regarding its effectiveness in healthy young adults remains limited.
Objective:
This study aims to investigate the effects of a 12-week BBAT program on musculoskeletal pain, spinal mobility, balance, and flexibility in healthy young adults.
Methods:
This randomized controlled trial will be conducted at the Healthy Living Laboratory of the University of Health Sciences, Gülhane Faculty of Physiotherapy and Rehabilitation, between June 2026 and May 2027. Healthy individuals aged 18-40 years will be recruited through social media announcements and voluntary participation. Participants will be randomly allocated to either an intervention group or a control group.
The intervention group will participate in BBAT sessions once weekly for 12 weeks, with each session lasting 45-60 minutes. The control group will receive no intervention during the study period. Inclusion criteria include being 18-40 years old, not having participated in structured body-awareness-based programs (e.g., BBAT, yoga, or Pilates) within the previous six months, and being able to complete the assessment procedures independently. Individuals with neurological, vestibular, rheumatological, or severe orthopedic disorders, recent surgery or injury affecting the spine or lower extremities, pregnancy, acute infection, or medications affecting balance will be excluded.
Spinal mobility and flexibility will be the primary outcome measure. Secondary outcomes will include musculoskeletal pain and balance. Assessments will be performed before and after the intervention period.
Sample size estimation was conducted using G*Power 3.1 based on a medium effect size (f = 0.25), α = 0.05, power = 80%, two groups, and two measurement points. The minimum required sample size was calculated as 36 participants. Considering a potential dropout rate of 15-20%, at least 40 participants (20 per group) will be recruited.
Hypotheses:
Compared with the control group, participants receiving BBAT are expected to demonstrate significantly greater improvements in (1) spinal mobility , (2) flexibility , (3)musculoskeletal pain, and (4) balance outcomes.
Tanulmány típusa
Beiratkozás (Becsült)
Fázis
- Nem alkalmazható
Kapcsolatok és helyek
Tanulmányi kapcsolat
- Név: Özge Çankaya, PhD
- Telefonszám: +905053732255
- E-mail: ozgemuezzinoglu@gmail.com
Tanulmányi helyek
-
-
-
Ankara, Törökország (Türkiye), 06100
- Toborzás
- University of Health Sciences
-
Kapcsolatba lépni:
- Özge Çankaya
- Telefonszám: +905053732255
- E-mail: ozgemuezzinoglu@gmail.com
-
-
Részvételi kritériumok
Jogosultsági kritériumok
Tanulmányozható életkorok
- Felnőtt
Egészséges önkénteseket fogad
Leírás
Inclusion Criteria:
- Age between 18 and 40 years.
- Ability to walk independently without assistive devices.
- No participation in structured body-awareness-based exercise programs (e.g., Basic Body Awareness Therapy, yoga, or Pilates) within the previous 6 months.
- Ability to understand study procedures and comply with assessment protocols.
- Willingness to participate and provision of written informed consent.
Exclusion Criteria:
- History of neurological, vestibular, rheumatologic, or severe orthopedic disorders that may affect movement, balance, or mobility.
- History of spinal or lower-extremity surgery or musculoskeletal injury within the previous 6 months.
- Severe musculoskeletal pain limiting participation in assessments or intervention sessions.
- Pregnancy.
- Current use of medications known to affect balance, postural control, or motor performance.
- Presence of acute infection or other acute medical conditions at the time of enrollment.
Tanulási terv
Hogyan készül a tanulmány?
Tervezési részletek
- Elsődleges cél: Támogató gondoskodás
- Kiosztás: Véletlenszerűsített
- Beavatkozó modell: Párhuzamos hozzárendelés
- Maszkolás: Egyetlen
Fegyverek és beavatkozások
Résztvevő csoport / kar |
Beavatkozás / kezelés |
|---|---|
|
Nincs beavatkozás: Control
The control group will be assessed for spinal mobility, flexibility, musculoskeletal pain, and balance at baseline and following a 12-week follow-up period.
Participants in this group will not receive any intervention throughout the study.
|
|
|
Kísérleti: Exercise
The intervention group will participate in supervised BBAT sessions once weekly for 12 weeks, with each session lasting 45-60 minutes. BBAT exercises include; Grounding Postural balance Co-ordination Breathing Flow Mental awareness |
Participants allocated to the intervention group will receive a 12-week Basic Body Awareness Therapy (BBAT) program. The intervention will be delivered once weekly on the same day and at the same time each week, with each session lasting approximately 45-60 minutes. The BBAT program will consist of structured exercises performed in supine, sitting, and standing positions, focusing on postural alignment, muscle activation and relaxation, breathing awareness, weight transfer, balance control, and movement quality. Individual and partner-based exercises will be used to enhance body awareness, postural stability, and coordinated movement patterns. All sessions will be supervised and conducted by a physiotherapist who has completed BBAT Level III training. Participants will be encouraged to perform the movements with attention to body awareness, balance, breathing, and movement efficiency throughout the intervention period. |
Mit mér a tanulmány?
Elsődleges eredményintézkedések
Eredménymérő |
Intézkedés leírása |
Időkeret |
|---|---|---|
|
Spinal mobility
Időkeret: Baseline and Week 12
|
Spinal mobility will be assessed using the Spinal Mouse® system (Idiag AG, Fehraltorf, Switzerland).
Measurements will be obtained in neutral standing, maximal flexion, maximal extension, and maximal lateral flexion positions.
Two measurements will be recorded for each position, and the average value will be used for analysis.
|
Baseline and Week 12
|
|
Flexibility
Időkeret: Baseline and Week 12
|
Flexibility of the lumbar region and lower extremities will be evaluated using the Sit-and-Reach Test.
Participants will perform three trials, and the best score (cm) will be recorded for analysis.
|
Baseline and Week 12
|
Másodlagos eredményintézkedések
Eredménymérő |
Intézkedés leírása |
Időkeret |
|---|---|---|
|
Musculoskeletal pain
Időkeret: Baseline and Week 12
|
Musculoskeletal pain and discomfort will be assessed using the Cornell Musculoskeletal Discomfort Questionnaire (CMDQ).
The CMDQ evaluates the frequency, severity, and functional impact of discomfort in different body regions.
Total CMDQ scores will be used for analysis.
|
Baseline and Week 12
|
|
Balance
Időkeret: Baseline and Week 12
|
Balance performance will be assessed using the HUR Balance® system.
Static and dynamic postural control parameters, including center-of-pressure sway and stability measures, will be recorded according to the standardized testing protocol.
|
Baseline and Week 12
|
Együttműködők és nyomozók
Szponzor
Együttműködők
Nyomozók
- Kutatásvezető: Özge Çankaya, Saglik Bilimleri Universitesi
Tanulmányi rekorddátumok
Tanulmány főbb dátumok
Tanulmány kezdete (Tényleges)
Elsődleges befejezés (Becsült)
A tanulmány befejezése (Becsült)
Tanulmányi regisztráció dátumai
Először benyújtva
Először nyújtották be, amely megfelel a minőségbiztosítási kritériumoknak
Első közzététel (Tényleges)
Tanulmányi rekordok frissítései
Utolsó frissítés közzétéve (Tényleges)
Az utolsó frissítés elküldve, amely megfelel a minőségbiztosítási kritériumoknak
Utolsó ellenőrzés
Több információ
A tanulmányhoz kapcsolódó kifejezések
További vonatkozó MeSH feltételek
Egyéb vizsgálati azonosító számok
- SBUBBAT
Terv az egyéni résztvevői adatokhoz (IPD)
Tervezi megosztani az egyéni résztvevői adatokat (IPD)?
Gyógyszer- és eszközinformációk, tanulmányi dokumentumok
Egy amerikai FDA által szabályozott gyógyszerkészítményt tanulmányoz
Egy amerikai FDA által szabályozott eszközterméket tanulmányoz
Ezt az információt közvetlenül a clinicaltrials.gov webhelyről szereztük be, változtatás nélkül. Ha bármilyen kérése van vizsgálati adatainak módosítására, eltávolítására vagy frissítésére, kérjük, írjon a következő címre: register@clinicaltrials.gov. Amint a változás bevezetésre kerül a clinicaltrials.gov oldalon, ez a webhelyünkön is automatikusan frissül. .